Should I Buy Alcoa Stock?
Alcoa (AA) finds itself in an interesting position in early…
Sell
35
IPHA Quote, Financials, Valuation and Earnings
Last price:
$1.79
Seasonality move
:
-1.32%
Day range:
$1.84 - $1.94
52-week range:
$1.29 - $3.51
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
11.42x
P/B ratio:
17.41x
Volume:
11.6K
Avg. volume:
60.2K
1-year change:
-28.73%
Market cap:
$160.1M
Revenue:
$13.7M
EPS (TTM):
-$0.45
Earnings Data
Next earnings date for IPHA
May 13
2025
Most recent earnings per share
--
Missed by --
(Apr 3/2025)
Consensus Estimate
--
(Apr 3/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
IPHA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/10/2020 | Q4 | -- | -- | -- | -$0.17 | -- |
| 11/13/2019 | Q3 | -- | -- | -- | $0.05 | -- |
Innate Pharma SA Earnings Questions
-
How Much did Innate Pharma SA Generate in Revenue Last Quarter?
Innate Pharma SA reported -- worth of top line sales in its most recent quarter.
-
Did Innate Pharma SA Beat Earnings Last Quarter?
Innate Pharma SA announced earnings per share of -- which represents a miss of analyst forecast a -- per share.
-
Is Innate Pharma SA Profitable?
Innate Pharma SA reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Innate Pharma SA EPS Next Year?
Innate Pharma SA's earnings are forecast to decrease from -$0.66 per share to -- per share next year representing a decrease of -55.87%.
-
When is Innate Pharma SA's Earnings Date?
Innate Pharma SA's next earnings date is May 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Nu Holdings Stock Be in 2030?
Despite fast growth, high profitability and an extraordinary runway ahead,…
Is it Too Late to Buy United Airlines Stock?
United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
GATE alert for Apr 2
Marblegate Acquisition [GATE] is up 86.64% over the past day.
Buy
52
NUTX alert for Apr 2
Nutex Health [NUTX] is up 5.41% over the past day.
Buy
75
CORT alert for Apr 2
Corcept Therapeutics [CORT] is down 8.84% over the past day.
